• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激在非酒精性脂肪性肝病-非酒精性脂肪性肝炎-肝细胞癌转变中的作用——聚焦于NADPH氧化酶

The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH Oxidases.

作者信息

Gabbia Daniela, Cannella Luana, De Martin Sara

机构信息

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.

出版信息

Biomedicines. 2021 Jun 17;9(6):687. doi: 10.3390/biomedicines9060687.

DOI:10.3390/biomedicines9060687
PMID:34204571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8235710/
Abstract

A peculiar role for oxidative stress in non-alcoholic fatty liver disease (NAFLD) and its transition to the inflammatory complication non-alcoholic steatohepatitis (NASH), as well as in its threatening evolution to hepatocellular carcinoma (HCC), is supported by numerous experimental and clinical studies. NADPH oxidases (NOXs) are enzymes producing reactive oxygen species (ROS), whose abundance in liver cells is closely related to inflammation and immune responses. Here, we reviewed recent findings regarding this topic, focusing on the role of NOXs in the different stages of fatty liver disease and describing the current knowledge about their mechanisms of action. We conclude that, although there is a consensus that NOX-produced ROS are toxic in non-neoplastic conditions due to their role in the inflammatory vicious cycle sustaining the transition of NAFLD to NASH, their effect is controversial in the neoplastic transition towards HCC. In this regard, there are indications of a differential effect of NOX isoforms, since NOX1 and NOX2 play a detrimental role, whereas increased NOX4 expression appears to be correlated with better HCC prognosis in some studies. Further studies are needed to fully unravel the mechanisms of action of NOXs and their relationships with the signaling pathways modulating steatosis and liver cancer development.

摘要

众多实验和临床研究支持氧化应激在非酒精性脂肪性肝病(NAFLD)及其向炎症性并发症非酒精性脂肪性肝炎(NASH)的转变,以及在其向肝细胞癌(HCC)的威胁性演变中所起的特殊作用。NADPH氧化酶(NOXs)是产生活性氧(ROS)的酶,其在肝细胞中的丰度与炎症和免疫反应密切相关。在此,我们回顾了关于该主题的最新发现,重点关注NOXs在脂肪性肝病不同阶段的作用,并描述了目前关于其作用机制的知识。我们得出结论,尽管人们一致认为,由于NOX产生的ROS在维持NAFLD向NASH转变的炎症恶性循环中起作用,其在非肿瘤性疾病中具有毒性,但其在向HCC的肿瘤性转变中的作用存在争议。在这方面,有迹象表明NOX亚型存在差异效应,因为NOX1和NOX2起有害作用,而在一些研究中,NOX4表达增加似乎与更好的HCC预后相关。需要进一步研究以全面阐明NOXs的作用机制及其与调节脂肪变性和肝癌发展的信号通路的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/8235710/752a493de5d2/biomedicines-09-00687-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/8235710/f1173a81ea1a/biomedicines-09-00687-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/8235710/b491500fb1cf/biomedicines-09-00687-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/8235710/752a493de5d2/biomedicines-09-00687-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/8235710/f1173a81ea1a/biomedicines-09-00687-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/8235710/b491500fb1cf/biomedicines-09-00687-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159e/8235710/752a493de5d2/biomedicines-09-00687-g003.jpg

相似文献

1
The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH Oxidases.氧化应激在非酒精性脂肪性肝病-非酒精性脂肪性肝炎-肝细胞癌转变中的作用——聚焦于NADPH氧化酶
Biomedicines. 2021 Jun 17;9(6):687. doi: 10.3390/biomedicines9060687.
2
NADPH Oxidases in Chronic Liver Diseases.慢性肝病中的NADPH氧化酶
Adv Hepatol. 2014 Nov 30;2014. doi: 10.1155/2014/742931.
3
The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.在与肝细胞癌相关的非酒精性脂肪性肝炎患者中,血清氧化/抗氧化应激平衡失调。
Intern Med. 2017;56(3):243-251. doi: 10.2169/internalmedicine.56.7002. Epub 2017 Feb 1.
4
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.非酒精性脂肪性肝病相关肝细胞癌:日益受到关注。
Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17.
5
Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population.NADPH 氧化酶的 CYBA 和 NOX4 基因与巴西人群非酒精性脂肪性肝病代谢综合征的关系。
Hepatobiliary Pancreat Dis Int. 2018 Aug;17(4):330-335. doi: 10.1016/j.hbpd.2018.06.005. Epub 2018 Jul 9.
6
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.高脂饮食诱导的非酒精性脂肪性肝病-非酒精性脂肪性肝炎-肝细胞癌进展中的微小RNA表达分析:对C57BL/6J小鼠的研究
BMC Cancer. 2016 Jan 5;16:3. doi: 10.1186/s12885-015-2007-1.
7
Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?存活素免疫表达降低可能是非酒精性脂肪性肝病进展的一个潜在标志物?
Liver Int. 2011 Mar;31(3):377-85. doi: 10.1111/j.1478-3231.2010.02370.x. Epub 2010 Nov 26.
8
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
9
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
10
Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs.异甘草酸镁通过抑制 NADPH 氧化酶减轻果糖诱导的肝脏氧化应激和炎症损伤。
Eur J Pharmacol. 2020 Sep 15;883:173314. doi: 10.1016/j.ejphar.2020.173314. Epub 2020 Jun 30.

引用本文的文献

1
Modulating nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 in liver-brain axis disorders.调节肝脑轴疾病中的核因子红细胞2相关因子2和血红素加氧酶-1
World J Psychiatry. 2025 Sep 19;15(9):108382. doi: 10.5498/wjp.v15.i9.108382.
2
Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy.肝癌中的基因组改变与微生物群串扰:肿瘤发生与治疗中的肠-肝轴
Genes (Basel). 2025 Jul 30;16(8):920. doi: 10.3390/genes16080920.
3
Targeting Lipophagy in Liver Diseases: Impact on Oxidative Stress and Steatohepatitis.

本文引用的文献

1
Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies.肝细胞癌的免疫格局与免疫治疗潜力
Front Immunol. 2021 Mar 18;12:655697. doi: 10.3389/fimmu.2021.655697. eCollection 2021.
2
Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease.参与小儿和成人非酒精性脂肪性肝病发病机制的肝淋巴细胞。
Sci Rep. 2021 Mar 4;11(1):5129. doi: 10.1038/s41598-021-84674-z.
3
Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy.
靶向肝脏疾病中的脂质自噬:对氧化应激和脂肪性肝炎的影响
Antioxidants (Basel). 2025 Jul 24;14(8):908. doi: 10.3390/antiox14080908.
4
Hepatoprotective Potential of Green Synthesized Nanoparticles from Peel Extract against HFS Diet-Induced NASH in Mice, Integrated with Chemical Profiling and Molecular Modeling.从果皮提取物绿色合成的纳米颗粒对高脂高糖饮食诱导的小鼠非酒精性脂肪性肝炎的肝保护潜力,结合化学剖析和分子建模
ACS Omega. 2025 Aug 11;10(32):36178-36202. doi: 10.1021/acsomega.5c03992. eCollection 2025 Aug 19.
5
Exploring the role of xanthine oxidase and aldehyde oxidase in metabolic dysfunction-associated steatotic liver disease (MASLD).探索黄嘌呤氧化酶和醛氧化酶在代谢功能障碍相关脂肪性肝病(MASLD)中的作用。
J Mol Histol. 2025 Jul 23;56(4):237. doi: 10.1007/s10735-025-10507-2.
6
Chemical Characterization and Differential Lipid-Modulating Effects of Selected Plant Extracts from Côa Valley (Portugal) in a Cell Model for Liver Steatosis.葡萄牙科阿山谷选定植物提取物在肝脂肪变性细胞模型中的化学表征及不同脂质调节作用
Pharmaceuticals (Basel). 2025 Jan 1;18(1):39. doi: 10.3390/ph18010039.
7
Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease.烟酰胺腺嘌呤二核苷酸磷酸氧化酶与代谢功能障碍相关脂肪性肝病
Antioxidants (Basel). 2025 Jan 13;14(1):83. doi: 10.3390/antiox14010083.
8
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development.肝细胞癌发生过程中病因依赖的微生物组差异
Int J Mol Sci. 2024 Dec 17;25(24):13510. doi: 10.3390/ijms252413510.
9
Mechanism of action of the nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome and its regulation in liver injury.核苷酸结合寡聚化结构域样受体蛋白3炎性小体的作用机制及其在肝损伤中的调节
Chin Med J (Engl). 2025 May 5;138(9):1061-1071. doi: 10.1097/CM9.0000000000003309. Epub 2024 Dec 23.
10
Diagnostic Value of Hepatic Mast Cell Concentration (MCC) in NAFLD and NASH Severity and Fibrosis Grade.肝组织肥大细胞浓度(MCC)对非酒精性脂肪性肝病(NAFLD)及非酒精性脂肪性肝炎(NASH)严重程度和纤维化分级的诊断价值
Iran J Pathol. 2024;19(3):291-299. doi: 10.30699/IJP.2024.2016320.3216. Epub 2024 Apr 29.
氧化应激在非酒精性脂肪性肝病发病机制中的作用:对预防和治疗的启示
Antioxidants (Basel). 2021 Jan 26;10(2):174. doi: 10.3390/antiox10020174.
4
Sirtuin 1 ameliorates defenestration in hepatic sinusoidal endothelial cells during liver fibrosis via inhibiting stress-induced premature senescence.沉默调节蛋白1通过抑制应激诱导的早衰来改善肝纤维化期间肝窦内皮细胞的窗孔减少。
Cell Prolif. 2021 Mar;54(3):e12991. doi: 10.1111/cpr.12991. Epub 2021 Feb 1.
5
NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice.NADPH 氧化酶 4(Nox4)缺失可加速小鼠的肝再生。
Redox Biol. 2021 Apr;40:101841. doi: 10.1016/j.redox.2020.101841. Epub 2020 Dec 23.
6
NOX1 inhibition attenuates the development of a pro-tumorigenic environment in experimental hepatocellular carcinoma.NOX1 抑制可减轻实验性肝细胞癌中促肿瘤环境的发展。
J Exp Clin Cancer Res. 2021 Jan 23;40(1):40. doi: 10.1186/s13046-021-01837-6.
7
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
8
Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的氧化特异性表位。
Front Endocrinol (Lausanne). 2020 Dec 9;11:607011. doi: 10.3389/fendo.2020.607011. eCollection 2020.
9
CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver.慢性粒细胞白血病/晚期糖基化终末产物受体信号通路架起动脉粥样硬化与非酒精性脂肪肝之间的共同发病机制桥梁。
Front Med (Lausanne). 2020 Nov 6;7:583943. doi: 10.3389/fmed.2020.583943. eCollection 2020.
10
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis - epidemiology, risk factors, clinical implications and treatment.非酒精性脂肪性肝炎患者的肝细胞癌——流行病学、危险因素、临床意义及治疗
Clin Exp Hepatol. 2020 Sep;6(3):170-175. doi: 10.5114/ceh.2020.99506. Epub 2020 Sep 30.